{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:54:26Z","timestamp":1784274866624,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.cllc.2017.06.019","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T23:16:38Z","timestamp":1499296598000},"page":"e131-e140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identifying the Optimal Radiation Dose in Locally Advanced Non\u2013Small-cell Lung Cancer Treated With Definitive Radiotherapy Without Concurrent Chemotherapy"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2229-6351","authenticated-orcid":false,"given":"Mark A.","family":"Sonnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Oro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernice","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiji","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7211-6246","authenticated-orcid":false,"given":"Daphna Y.","family":"Gelblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen D.","family":"Yorke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5838-9982","authenticated-orcid":false,"given":"Jamie E.","family":"Chaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1214-3856","authenticated-orcid":false,"given":"Andreas","family":"Rimner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2017.06.019_bib1","series-title":"United States Cancer Statistics: 1999-2013 Incidence and Mortality Web-based Report","year":"2016"},{"key":"10.1016\/j.cllc.2017.06.019_bib2","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/cncr.21007","article-title":"Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma","volume":"103","author":"Rosenzweig","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2017.06.019_bib3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijrobp.2005.02.010","article-title":"High-dose radiation improved local tumor control and overall survival in patients with inoperable\/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study","volume":"63","author":"Kong","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2017.06.019_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijrobp.2004.06.260","article-title":"Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma","volume":"61","author":"Bradley","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2017.06.019_bib5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJM199010043231403","article-title":"A\u00a0randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer","volume":"323","author":"Dillman","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2017.06.019_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jnci\/87.3.198","article-title":"Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer","volume":"87","author":"Sause","year":"1995","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2017.06.019_bib7","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","article-title":"Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410","volume":"103","author":"Curran","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2017.06.019_bib8","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Auperin","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2017.06.019_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2017.06.019_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/annonc\/mdu268","article-title":"A\u00a0review of the management of elderly patients with non-small-cell lung cancer","volume":"26","author":"Blanco","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2017.06.019_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/annonc\/mdn559","article-title":"Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study","volume":"20","author":"De Ruysscher","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2017.06.019_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cllc.2014.02.003","article-title":"Stage III non-small-cell lung cancer: establishing a benchmark for the proportion of patients suitable for radical treatment","volume":"15","author":"Al-Shamsi","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2017.06.019_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/PPO.0b013e31813ffd7b","article-title":"High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer","volume":"13","author":"Sura","year":"2007","journal-title":"Cancer J"},{"key":"10.1016\/j.cllc.2017.06.019_bib14","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2017.06.019_bib15","first-page":"126","article-title":"Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?","volume":"5","author":"Hong","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.cllc.2017.06.019_bib16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ijrobp.2016.07.022","article-title":"Dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer: meta-analysis of randomized trials","volume":"96","author":"Ramroth","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2017.06.019_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s13014-014-0283-6","article-title":"The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy","volume":"9","author":"Koo","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.cllc.2017.06.019_bib18","doi-asserted-by":"crossref","first-page":"djv004","DOI":"10.1093\/jnci\/djv004","article-title":"Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668\/RTOG 0235","volume":"107","author":"Ohri","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2017.06.019_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2007.06.034","article-title":"Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer","volume":"70","author":"Werner-Wasik","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2017.06.019_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.radonc.2016.02.008","article-title":"Differential analysis of local and regional failure in locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy","volume":"118","author":"van Diessen","year":"2016","journal-title":"Radiother Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730417302061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730417302061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:08:06Z","timestamp":1761505686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730417302061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1525730417302061"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2017.06.019","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying the Optimal Radiation Dose in Locally Advanced Non\u2013Small-cell Lung Cancer Treated With Definitive Radiotherapy Without Concurrent Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2017.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}